staff reporter
Articles Authored by staff reporter
Autolus Reports Steady Progress for Aucatzyl's US Launch, Anticipating European Approvals in 2025
The firm also said its partner BioNTech won't exercise its option rights for the CD19- and CD22-directed CAR T-cell therapy candidate AUTO1/22.
Cargo Therapeutics Suspends Last CAR T-Cell Therapy Program, Reduces Workforce by 90 Percent
The firm is also shuttering its allogeneic cell therapy platform and has tasked a new CEO to lead the company through a merger.
Novartis to Seek Approval for Intrathecal SMA Gene Therapy in Children, Young Adults in Early 2025
An intravenous form of the gene therapy is already approved and sold as Zolgensma in the US for patients less than 2 years of age.
Proscia Nabs $50M in Funding to Support Commercialization of Digital Pathology Software
The firm said that the money will support work with OEM partners and the expanded development and integration of artificial intelligence-based tools.
Servier Licenses Black Diamond Therapeutics' RAF-Targeted Solid Tumor Candidate
In a $780 million deal, Servier is obtaining global rights to develop and commercialize BDTX-4933 in multiple solid tumors with RAS or RAF mutations.
InformedDNA Acquires Coriell Life Sciences, Adds PGx Capabilities
The companies have begun integrating Coriell's PGx services into InformedDNA's DNAimpact precision health platform for payors and employers.
Patient Dies After Treatment With Sarepta's Duchenne Muscular Dystrophy Gene Therapy
The firm's stock price dropped 27 percent on Tuesday following the news that the young man died from acute liver failure after getting Elevidys.
Actinium Launches Clinical Program to Test Actimab-A With PD-1 Inhibitors in Solid Tumors
The firm will assess whether adding its CD33-targeted radiotherapy Actimab-A to PD-1 inhibitors will benefit patients more than PD-1 inhibitors alone.
Arbor Biotechnologies Raises $73.9M in Series C Funding to Advance Gene-Editing Drugs
The firm will use the funds to develop its lead candidate in primary hyperoxaluria type 1 and other pipeline products in liver and CNS disorders.
Labor Dr. Wisplinghoff, Genomic Testing Cooperative Partner to Offer Cancer Testing in Germany
Labor Dr. Wisplinghoff will offer GTC's next-generation sequencing-based tests for solid tumor and hematologic neoplasms.